✦ LIBER ✦

Factors associated with ejaculatory and orgasmic dysfunction in men with erectile dysfunction: analysis of clinical trials involving the phosphodiesterase type 5 inhibitor tadalafil

✍ Scribed by Darius A. Paduch; Alexander Bolyakov; Anthony Beardsworth; Steven D. Watts

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibition of phosphodiesterase type 5 w

✍ Massimo Bocchio; Fiore Pelliccione; Gabriella Passaquale; Radu Mihalca; Stefano 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 298 KB

Efficacy of Tadalafil in Men with Erecti

✍ Gregory A. Broderick; Craig F. Donatucci; Dimitrios Hatzichristou; Luiz O. Torre 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Improvement in duration of erection foll

✍ M. T. Rosenberg; P. L. Adams; T. A. McBride; J. N. Roberts; S. W. McCallum 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

Efficacy of Phosphodiesterase Type 5 Inh

✍ Martin M. Miner; Allison Barnes; Stephen Janning 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

Phosphodiesterase Type 5 Inhibitors in P

✍ Konstantinos Hatzimouratidis; Arthur L. Burnett; Dimitrios Hatzichristou; Andrew 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 636 KB

The Efficacy and Safety of Udenafil, a N

✍ Jae-Seung Paick; Sae Woong Kim; Dae Yeol Yang; Ja Jong Kim; Sung Won Lee; Tai Yo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB